{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:46:38Z","timestamp":1782467198273,"version":"3.54.5"},"reference-count":178,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Leading Talent Training Program of Pudong New Area Health Commission, Shanghai","award":["PWR12025-03"],"award-info":[{"award-number":["PWR12025-03"]}]},{"name":"Discipline Leader Training Program of Pudong New Area Health Commission","award":["PWRd2023-14"],"award-info":[{"award-number":["PWRd2023-14"]}]},{"name":"Innovative Chinese Medicine Research Institute, Department of Pharmacy, Shanghai Seventh People\u2019s Hospital","award":["25-LCYJS-02"],"award-info":[{"award-number":["25-LCYJS-02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by limited actionable targets, early recurrence, metastatic propensity, and variable responses to immune checkpoint blockade. Therapeutic resistance is closely associated with myeloid immunosuppression, in which tumor-associated macrophages (TAMs) promote T-cell exclusion, stromal remodeling, angiogenesis, metabolic dysfunction, and resistance to cytotoxic and immune-based therapies. Anthraquinone compounds, including emodin, aloe-emodin, rhein, and chrysophanol, may support TAM reprogramming by regulating tumor-cell stress responses, endoplasmic reticulum stress, immunogenic cell death-associated signaling, redox balance, immunometabolism, and STAT3\/NF-\u03baB-related inflammatory pathways. However, poor aqueous solubility, heterogeneous biodistribution, unstable systemic exposure, and potential off-target toxicity limit their translational development. Liposomal delivery offers a formulation strategy to improve solubilization, biodistribution, TAM-associated uptake\/engagement, intracellular release, and therapeutic exposure windows. This review discusses anthraquinone-loaded liposomes for TAM reprogramming in TNBC by integrating mechanistic rationale, evidence boundaries, delivery logic, formulation determinants, and translational challenges, with particular attention to stress chaperone proteins, lipid composition, vesicle lamellarity, membrane phase state, responsive release, clinically relevant liposomal formulations, and clinical developability. Overall, anthraquinone-loaded liposomes are better positioned as immune microenvironment recalibration platforms or synergistic modulators in combination therapy rather than as standalone cytotoxic agents for TNBC.<\/jats:p>","DOI":"10.3390\/pharmaceutics18070781","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:43:57Z","timestamp":1782463437000},"page":"781","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anthraquinone-Loaded Liposomes for TAM Reprogramming in Triple-Negative Breast Cancer: Mechanistic Rationale, Delivery Logic, and Translational Challenges"],"prefix":"10.3390","volume":"18","author":[{"given":"Limin","family":"Zhai","sequence":"first","affiliation":[{"name":"Innovative Chinese Medicine Research Institute, Department of Pharmacy, Shanghai Seventh People\u2019s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[{"name":"Innovative Chinese Medicine Research Institute, Department of Pharmacy, Shanghai Seventh People\u2019s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Mu","sequence":"additional","affiliation":[{"name":"Innovative Chinese Medicine Research Institute, Department of Pharmacy, Shanghai Seventh People\u2019s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Li","sequence":"additional","affiliation":[{"name":"Innovative Chinese Medicine Research Institute, Department of Pharmacy, Shanghai Seventh People\u2019s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Innovative Chinese Medicine Research Institute, Department of Pharmacy, Shanghai Seventh People\u2019s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[{"name":"Innovative Chinese Medicine Research Institute, Department of Pharmacy, Shanghai Seventh People\u2019s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuzhen","family":"Zhu","sequence":"additional","affiliation":[{"name":"Innovative Chinese Medicine Research Institute, Department of Pharmacy, Shanghai Seventh People\u2019s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Hou","sequence":"additional","affiliation":[{"name":"Innovative Chinese Medicine Research Institute, Department of Pharmacy, Shanghai Seventh People\u2019s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourong","family":"Shi","sequence":"additional","affiliation":[{"name":"Innovative Chinese Medicine Research Institute, Department of Pharmacy, Shanghai Seventh People\u2019s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fan","sequence":"additional","affiliation":[{"name":"Innovative Chinese Medicine Research Institute, Department of Pharmacy, Shanghai Seventh People\u2019s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-Negative Breast Cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s40364-024-00714-6","article-title":"Tumor Microenvironment and Immunotherapy for Triple-Negative Breast Cancer","volume":"12","author":"Guo","year":"2024","journal-title":"Biomark. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.annonc.2025.07.017","article-title":"Updated Treatment Recommendations for Systemic Treatment: From the ESMO Metastatic Breast Cancer Living Guideline","volume":"36","author":"Trapani","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Zhou, Z., and Zhou, Q. (2025). Immunotherapy Resistance in Triple-Negative Breast Cancer: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Implications. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1630464"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"103012","DOI":"10.1016\/j.ctrv.2025.103012","article-title":"Combining Antibody-Drug Conjugates with Immune Checkpoint Inhibitors: A New Paradigm for Breast Cancer Therapy","volume":"140","author":"Xu","year":"2025","journal-title":"Cancer Treat. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Yang, Y., Li, H., Yang, W., and Shi, Y. (2024). Improving Efficacy of TNBC Immunotherapy: Based on Analysis and Subtyping of Immune Microenvironment. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1441667"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","article-title":"Towards Targeting the Breast Cancer Immune Microenvironment","volume":"24","author":"Harris","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13046-025-03394-8","article-title":"Reprogramming the Breast Tumor Immune Microenvironment: Cold-to-Hot Transition for Enhanced Immunotherapy","volume":"44","author":"Imani","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.trecan.2024.12.003","article-title":"Recent Developments in Myeloid Immune Modulation in Cancer Therapy","volume":"11","author":"Parvanian","year":"2025","journal-title":"Trends Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wang, Z.-X., Chu, J.-H., Wang, Y.-R., Huang, L.-Y., and Qian, M.-P. (2026). Immunotherapy Innovations in Triple-Negative Breast Cancer: Targeting Checkpoints, Combinations, and Biomarkers. Oncol. Rev., 20.","DOI":"10.3389\/or.2026.1802090"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.12701\/jyms.2026.43.17","article-title":"Immunotherapy in Triple-Negative Breast Cancer: Mechanisms of Resistance and Emerging Approaches: A Narrative Review","volume":"43","author":"Koh","year":"2026","journal-title":"J. Yeungnam Med. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Jin, H., Meng, X., and Feng, J. (2025). Mechanisms of Tumor-Associated Macrophages in Breast Cancer and Treatment Strategy. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1560393"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wu, T., and Liao, Y. (2025). Roles of Tumor-Associated Macrophages in Triple-Negative Breast Cancer Progression. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1677363"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-Associated Macrophages Remodel the Suppressive Tumor Immune Microenvironment and Targeted Therapy for Immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of Tumor-Associated Macrophages in Anti-PD-1\/PD-L1 Immunotherapy for Solid Cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","article-title":"Tumor-Associated Macrophages Restrict CD8+ T Cell Function through Collagen Deposition and Metabolic Reprogramming of the Breast Cancer Microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual Roles and Therapeutic Targeting of Tumor-Associated Macrophages in Tumor Microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.it.2023.10.007","article-title":"Tumor Macrophage Functional Heterogeneity Can Inform the Development of Novel Cancer Therapies","volume":"44","author":"Nasir","year":"2023","journal-title":"Trends Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s00262-021-02861-3","article-title":"Activity of Tumor-Associated Macrophage Depletion by CSF1R Blockade Is Highly Dependent on the Tumor Model and Timing of Treatment","volume":"70","author":"Orf","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_20","first-page":"e31063","article-title":"Plant Anthraquinones: Classification, Distribution, Biosynthesis, and Regulation","volume":"239","author":"Wang","year":"2024","journal-title":"J. Cell. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"35806","DOI":"10.1039\/D1RA05686G","article-title":"Journey of Anthraquinones as Anticancer Agents\u2014A Systematic Review of Recent Literature","volume":"11","author":"Malik","year":"2021","journal-title":"RSC Adv."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mihaylova, R., Elincheva, V., Simeonova, R., and Momekov, G. (2026). Emodin and the Anthraquinone Scaffold: Therapeutic Promise and Strategies to Overcome Translational Barriers. Molecules, 31.","DOI":"10.3390\/molecules31050833"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Xin, D., Li, H., Zhou, S., Zhong, H., and Pu, W. (2022). Effects of Anthraquinones on Immune Responses and Inflammatory Diseases. Molecules, 27.","DOI":"10.3390\/molecules27123831"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.7150\/ijbs.70447","article-title":"The Versatile Emodin: A Natural Easily Acquired Anthraquinone Possesses Promising Anticancer Properties against a Variety of Cancers","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhao, L., and Zheng, L. (2023). A Review on Bioactive Anthraquinone and Derivatives as the Regulators for ROS. Molecules, 28.","DOI":"10.3390\/molecules28248139"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1535-7163.MCT-15-0987","article-title":"Emodin Inhibits Breast Cancer Growth by Blocking the Tumor-Promoting Feedforward Loop between Cancer Cells and Macrophages","volume":"15","author":"Iwanowycz","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10549-014-3164-7","article-title":"Emodin Suppresses Pulmonary Metastasis of Breast Cancer Accompanied with Decreased Macrophage Recruitment and M2 Polarization in the Lungs","volume":"148","author":"Jia","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11491","DOI":"10.1074\/jbc.M115.702092","article-title":"Emodin Bidirectionally Modulates Macrophage Polarization and Epigenetically Regulates Macrophage Memory","volume":"291","author":"Iwanowycz","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Xie, J., Zhang, J., and Chen, X. (2026). Aloe-Emodin: From Pharmacological Mechanisms to Clinical Applications and Future Perspectives. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1741679"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Fu, Y., Yang, L., Liu, L., Kong, L., Sun, H., Sun, Y., Yin, F., Yan, G., and Wang, X. (2024). Rhein: An Updated Review Concerning Its Biological Activity, Pharmacokinetics, Structure Optimization, and Future Pharmaceutical Applications. Pharmaceuticals, 17.","DOI":"10.3390\/ph17121665"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2021.12.001","article-title":"Liposome-Encapsulated Anthraquinone Improves Efficacy and Safety in Triple Negative Breast Cancer","volume":"342","author":"George","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-025-02357-z","article-title":"Precision Nanomedicine: Navigating the Tumor Microenvironment for Enhanced Cancer Immunotherapy and Targeted Drug Delivery","volume":"24","author":"Sabit","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","article-title":"A Translational Framework to DELIVER Nanomedicines to the Clinic","volume":"19","author":"Joyce","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wang, D., Wang, X.-H., Yu, X., Cao, F., Cai, X., Chen, P., Li, M., Feng, Y., Li, H., and Wang, X. (2021). Pharmacokinetics of Anthraquinones from Medicinal Plants. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.638993"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e33631","DOI":"10.1016\/j.heliyon.2024.e33631","article-title":"Advances in the Mechanism of Emodin-Induced Hepatotoxicity","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"115239","DOI":"10.1016\/j.addr.2024.115239","article-title":"Nanocarriers Address Intracellular Barriers for Efficient Drug Delivery, Overcoming Drug Resistance, Subcellular Targeting and Controlled Release","volume":"207","author":"Liu","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"113851","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome Composition in Drug Delivery Design, Synthesis, Characterization, and Clinical Application","volume":"176","author":"Large","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12951-024-02622-1","article-title":"Engineering Nanoparticles-Enabled Tumor-Associated Macrophages Repolarization and Phagocytosis Restoration for Enhanced Cancer Immunotherapy","volume":"22","author":"Gong","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zheng, J., Jiang, J., Pu, Y., Xu, T., Sun, J., Zhang, Q., He, L., and Liang, X. (2023). Tumor-Associated Macrophages in Nanomaterial-Based Anti-Tumor Therapy: As Target Spots or Delivery Platforms. Front. Bioeng. Biotechnol., 11.","DOI":"10.3389\/fbioe.2023.1248421"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of Mononuclear Phagocyte System Blockade for Nanoparticle Drug Delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s44222-023-00138-1","article-title":"Controlling the Biodistribution and Clearance of Nanomedicines","volume":"2","author":"Cabral","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1039\/D4NA00783B","article-title":"An Investigation of the Effect of the Protein Corona on the Cellular Uptake of Nanoliposomes under Flow Conditions Using Quartz Crystal Microgravimetry with Dissipation","volume":"7","author":"Paun","year":"2025","journal-title":"Nanoscale Adv."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s44222-024-00203-3","article-title":"Nanoparticle Delivery to Tumours: From EPR and ATR Mechanisms to Clinical Impact","volume":"2","author":"Dasgupta","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"10232","DOI":"10.1038\/s41467-024-54145-w","article-title":"Spatial Transcriptomics Reveals Substantial Heterogeneity in Triple-Negative Breast Cancer with Potential Clinical Implications","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1038\/s41467-025-61034-3","article-title":"Integrative Spatial Omics Reveals Distinct Tumor-Promoting Multicellular Niches and Immunosuppressive Mechanisms in Black American and White American Patients with TNBC","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s43018-025-00986-3","article-title":"The Tumor Microenvironment\u2019s Role in the Response to Immune Checkpoint Blockade","volume":"6","author":"Aliazis","year":"2025","journal-title":"Nat. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Figueroa, S., Reyes, N., Tiwari, R.K., and Geliebter, J. (2026). Targeting the Tumor Microenvironment in Triple-Negative Breast Cancer: Emerging Roles of Monoclonal Antibodies and Immune Modulation. Cancers, 18.","DOI":"10.3390\/cancers18030412"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ma, C., Teoh, H.K., Zhao, Y., Wang, Y., Zhao, J., Liu, Y., Zhao, C., and Ong, H.T. (2026). Reprogramming the Immunosuppressive Breast Cancer Microenvironment: Integrating Cellular, Metabolic, and Stromal Targets for Rational Immunotherapy. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1760782"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"115414","DOI":"10.1016\/j.biopha.2023.115414","article-title":"Subverted Macrophages in the Triple-Negative Breast Cancer Ecosystem","volume":"166","author":"Shang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Jin, X., Zhang, N., Yan, T., Wei, J., Hao, L., Sun, C., Zhao, H., and Jiang, S. (2025). Lactate-Mediated Metabolic Reprogramming of Tumor-Associated Macrophages: Implications for Tumor Progression and Therapeutic Potential. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1573039"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s42003-023-04525-7","article-title":"Tissue-Resident Macrophages Are Major Tumor-Associated Macrophage Resources, Contributing to Early TNBC Development, Recurrence, and Metastases","volume":"6","author":"Hirano","year":"2023","journal-title":"Commun. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like Tumor-Associated Macrophages Is a Potential Therapeutic Approach to Overcome Antitumor Drug Resistance","volume":"8","author":"Wang","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Xiao, M., He, J., Yin, L., Chen, X., Zu, X., and Shen, Y. (2021). Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.799428"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jare.2024.12.043","article-title":"Targeting Macrophages in Cancer Immunotherapy: Frontiers and Challenges","volume":"76","author":"Liu","year":"2025","journal-title":"J. Adv. Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Pei, Y., Zhang, J., Li, C., Wang, Y., Yu, Q., and Chen, W. (2026). From Tumor Microenvironment Orchestrators to Actionable Targets: A Systematic Review of TAM-Targeted Therapies in Triple-Negative Breast Cancer. Int. J. Clin. Oncol., ahead of print.","DOI":"10.1007\/s10147-026-02987-3"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12943-024-02064-1","article-title":"Decoding the Spatiotemporal Heterogeneity of Tumor-Associated Macrophages","volume":"23","author":"Chu","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7378","DOI":"10.7150\/thno.113727","article-title":"Focusing on the Interplay between Tumor-Associated Macrophages and Tumor Microenvironment: From Mechanism to Intervention","volume":"15","author":"Wu","year":"2025","journal-title":"Theranostics"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Tomassetti, C., Insinga, G., Gimigliano, F., Morrione, A., Giordano, A., and Giurisato, E. (2024). Insights into CSF-1R Expression in the Tumor Microenvironment. Biomedicines, 12.","DOI":"10.3390\/biomedicines12102381"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13578-024-01201-z","article-title":"Macrophage Heterogeneity and Its Interactions with Stromal Cells in Tumour Microenvironment","volume":"14","author":"Cao","year":"2024","journal-title":"Cell Biosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.trecan.2024.12.002","article-title":"Embracing Diversity: Macrophage Complexity in Cancer","volume":"11","author":"Hochstadt","year":"2025","journal-title":"Trends Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","article-title":"Macrophage Diversity in Cancer Revisited in the Era of Single-Cell Omics","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Qiu, X., Zhao, T., Luo, R., Qiu, R., and Li, Z. (2022). Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.772615"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic Microenvironment in Cancer: Molecular Mechanisms and Therapeutic Interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41416-024-02715-6","article-title":"Clinical Landscape of Macrophage-Reprogramming Cancer Immunotherapies","volume":"131","author":"Rannikko","year":"2024","journal-title":"Br. J. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/s41375-024-02391-8","article-title":"IL-10R Inhibition Reprograms Tumor-Associated Macrophages and Reverses Drug Resistance in Multiple Myeloma","volume":"38","author":"Sun","year":"2024","journal-title":"Leukemia"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/08830185.2024.2411998","article-title":"Transforming Growth Factor-\u03b2 in Tumor Microenvironment: Understanding Its Impact on Monocytes and Macrophages for Its Targeting","volume":"44","author":"Hourani","year":"2025","journal-title":"Int. Rev. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.trecan.2023.05.003","article-title":"Interleukin-10 in Cancer Immunotherapy: From Bench to Bedside","volume":"9","author":"Salkeni","year":"2023","journal-title":"Trends Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 Signaling in Health, Disease and Therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1038\/s12276-023-01114-w","article-title":"Normalization of the Tumor Microenvironment by Harnessing Vascular and Immune Modulation to Achieve Enhanced Cancer Therapy","volume":"55","author":"Choi","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Du, W., Xia, X., Hu, F., and Yu, J. (2024). Extracellular Matrix Remodeling in the Tumor Immunity. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1340634"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Ji, Y., Li, X., Yao, X., Sun, J., Yi, J., Shen, Y., Chen, B., and Sun, H. (2025). Macrophage Polarization: Molecular Mechanisms, Disease Implications, and Targeted Therapeutic Strategies. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1732718"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Xia, T., Zhang, M., Lei, W., Yang, R., Fu, S., Fan, Z., Yang, Y., and Zhang, T. (2023). Advances in the Role of STAT3 in Macrophage Polarization. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1160719"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Cornice, J., Verzella, D., Arboretto, P., Vecchiotti, D., Capece, D., Zazzeroni, F., and Franzoso, G. (2024). NF-\u03baB: Governing Macrophages in Cancer. Genes, 15.","DOI":"10.3390\/genes15020197"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"115513","DOI":"10.1016\/j.biopha.2023.115513","article-title":"Targeting the STAT3 Oncogenic Pathway: Cancer Immunotherapy and Drug Repurposing","volume":"167","author":"Dong","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"115090","DOI":"10.1016\/j.biopha.2023.115090","article-title":"Revisiting of TAMs in Tumor Immune Microenvironment: Insight from NF-\u03baB Signaling Pathway","volume":"165","author":"He","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-\u03baB in Inflammation and Cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s43018-025-00909-2","article-title":"Linking Macrophage Metabolism to Function in the Tumor Microenvironment","volume":"6","author":"Jin","year":"2025","journal-title":"Nat. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.cell.2023.02.020","article-title":"Macrophages at the Interface of the Co-Evolving Cancer Ecosystem","volume":"186","author":"Kloosterman","year":"2023","journal-title":"Cell"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"115332","DOI":"10.1016\/j.ejca.2025.115332","article-title":"Immunometabolism of Tumor-Associated Macrophages: A Therapeutic Perspective","volume":"220","author":"Karimova","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s13402-023-00881-y","article-title":"Targeting the Lipid Metabolic Reprogramming of Tumor-Associated Macrophages: A Novel Insight into Cancer Immunotherapy","volume":"47","author":"Li","year":"2024","journal-title":"Cell. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41423-024-01148-8","article-title":"Cellular Metabolism Regulates the Differentiation and Function of T-Cell Subsets","volume":"21","author":"Ma","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Gu, X.-Y., Yang, J.-L., Lai, R., Zhou, Z.-J., Tang, D., Hu, L., and Zhao, L.-J. (2025). Impact of Lactate on Immune Cell Function in the Tumor Microenvironment: Mechanisms and Therapeutic Perspectives. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1563303"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"116463","DOI":"10.1016\/j.celrep.2025.116463","article-title":"Metabolic Regulation of Immunity in the Tumor Microenvironment","volume":"44","author":"Li","year":"2025","journal-title":"Cell Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in Immunoregulation and Therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ccell.2022.05.004","article-title":"Spatiotemporal Co-Dependency between Macrophages and Exhausted CD8+ T Cells in Cancer","volume":"40","author":"Kersten","year":"2022","journal-title":"Cancer Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12943-025-02481-w","article-title":"Tumor-Associated Macrophages: Untapped Molecular Targets to Improve T Cell-Based Immunotherapy","volume":"24","author":"Coelho","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccell.2026.01.020","article-title":"Macrophages: Targets for next-Generation Cancer Immunotherapy","volume":"44","author":"Sun","year":"2026","journal-title":"Cancer Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1021\/acsnano.3c12387","article-title":"Nanomaterials-Involved Tumor-Associated Macrophages\u2019 Reprogramming for Antitumor Therapy","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"113538","DOI":"10.1016\/j.isci.2025.113538","article-title":"Macrophage Repolarization by Immune Checkpoint Blockade Drives T Cell Engagement in the Tumor Microenvironment","volume":"28","author":"Kwok","year":"2025","journal-title":"iScience"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Brancewicz, J., and Kucharzewska, P. (2025). Emerging Macrophage-Based Therapies for Cancer: A Review of Preclinical and Clinical Advances. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1679271"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"168176","DOI":"10.1016\/j.bbadis.2026.168176","article-title":"Leveraging Macrophage Plasticity for Precision-Targeted Tumor Immunotherapy","volume":"1872","author":"Li","year":"2026","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Basis Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"114401","DOI":"10.1016\/j.addr.2022.114401","article-title":"Sustained Delivery Approaches to Improving Adaptive Immune Responses","volume":"187","author":"Ou","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1158\/2326-6066.CIR-24-0797","article-title":"Sustained Macrophage Reprogramming Is Required for CD8+ T Cell\u2013Dependent Long-Term Tumor Eradication","volume":"13","author":"Jardim","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Zhang, H., Hu, N., Wang, Z., and Zhai, S. (2025). Liposome-Mediated Macrophage Reprogramming: Emerging Strategies for Chronic Disease Therapy. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1653642"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Zheng, A., Xie, F., Shi, S., Liu, S., Long, J., and Xu, Y. (2022). Sustained Drug Release From Liposomes for the Remodeling of Systemic Immune Homeostasis and the Tumor Microenvironment. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.829391"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s13402-026-01197-3","article-title":"Targeting Senescence-like Tumor-Associated Macrophages Sensitizes Chemotherapy in Triple-Negative Breast Cancer","volume":"49","author":"Zhou","year":"2026","journal-title":"Cell. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1007\/s00210-024-03612-8","article-title":"Sennoside A Represses the Malignant Phenotype and Tumor Immune Microenvironment of Non-Small Cell Lung Cancer Cells by Inhibiting the TRAF6\/NF-\u03baB Pathway","volume":"398","author":"Xia","year":"2025","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Hwang, Y.-H., Kim, S.-J., and Yee, S.-T. (2020). Physcion-Matured Dendritic Cells Induce the Differentiation of Th1 Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051753"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"156958","DOI":"10.1016\/j.phymed.2025.156958","article-title":"Targeting Tumor Metabolism: The Dual Attack of Emodin on Glycolysis and Oxidative Phosphorylation in Esophageal Squamous Cell Carcinoma","volume":"144","author":"Su","year":"2025","journal-title":"Phytomedicine"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"168020","DOI":"10.1016\/j.bbadis.2025.168020","article-title":"Mechanistic and Target Study of Anthraquinone Modifier KA-4c Triggering Endoplasmic Reticulum Stress to Inhibit Triple-Negative Breast Cancer Cells","volume":"1871","author":"Yang","year":"2025","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Basis Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41568-025-00836-5","article-title":"Endoplasmic Reticulum Stress Responses in Anticancer Immunity","volume":"25","author":"Hwang","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting Immunogenic Cell Stress and Death for Cancer Therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Birmpilis, A.I., Paschalis, A., Mourkakis, A., Christodoulou, P., Kostopoulos, I.V., Antimissari, E., Terzoudi, G., Georgakilas, A.G., Armpilia, C., and Papageorgis, P. (2022). Immunogenic Cell Death, DAMPs and Prothymosin \u03b1 as a Putative Anticancer Immune Response Biomarker. Cells, 11.","DOI":"10.3390\/cells11091415"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1016\/j.molcel.2025.09.007","article-title":"DAMPs in the Immunogenicity of Cell Death","volume":"85","author":"Chen","year":"2025","journal-title":"Mol. Cell"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Zhang, M., and Bi, X. (2024). Heat Shock Proteins and Breast Cancer. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25020876"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e2412246122","DOI":"10.1073\/pnas.2412246122","article-title":"Stress induced Translocation of the Endoplasmic Reticulum Chaperone GRP78\/BiP and Its Impact on Human Disease and Therapy","volume":"122","author":"Lee","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12935-025-03979-5","article-title":"GRP-Based Vaccines as a Novel Approach in Cancer Immunotherapy: Mechanisms, Challenges, and Prospects","volume":"25","author":"Shahreza","year":"2025","journal-title":"Cancer Cell Int."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12645-023-00237-z","article-title":"Polymer Lipid Hybrid Nanoparticles Encapsulated with Emodin Combined with DOX Reverse Multidrug Resistance of Breast Cancer via IL-6\/JAK2\/STAT3 Signaling Pathway","volume":"15","author":"Gu","year":"2024","journal-title":"Cancer Nano"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10142-024-01407-x","article-title":"Emodin Inhibits M1 Macrophage Activation That Related to Acute and Chronic Kidney Injury through EGFR\/MAPK Pathway","volume":"24","author":"Xiong","year":"2024","journal-title":"Funct. Integr. Genom."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"155763","DOI":"10.1016\/j.phymed.2024.155763","article-title":"Emodin Nanocapsules Inhibit Acute Pancreatitis by Regulating Lipid Metabolic Reprogramming in Macrophage Polarization","volume":"130","author":"Song","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cytogfr.2025.01.003","article-title":"Insights into IL-6\/JAK\/STAT3 Signaling in the Tumor Microenvironment: Implications for Cancer Therapy","volume":"85","author":"Thuya","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2022.11.005","article-title":"NF-\u03baB Dynamics in the Language of Immune Cells","volume":"44","author":"Aqdas","year":"2023","journal-title":"Trends Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cels.2024.05.002","article-title":"Stimulus-Response Signaling Dynamics Characterize Macrophage Polarization States","volume":"15","author":"Singh","year":"2024","journal-title":"Cell Syst."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"107050","DOI":"10.1016\/j.jddst.2025.107050","article-title":"Navigating Tumor Microenvironment with TME-Responsive Nanocarriers: Strategies for Targeted Drug Delivery in Solid Tumor","volume":"110","author":"Rajankar","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"106688","DOI":"10.1016\/j.ejps.2023.106688","article-title":"Recent Advances and Clinical Translation of Liposomal Delivery Systems in Cancer Therapy","volume":"193","author":"Chen","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"589401","DOI":"10.2147\/IJN.S589401","article-title":"Emodin-Based Drug Delivery Systems: Therapeutic Applications in Inflammatory Diseases","volume":"21","author":"Wang","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"115355","DOI":"10.1016\/j.colsurfb.2025.115355","article-title":"Plasma Pre-Incubation: Concentration-Dependent Regulation of the Biomolecular Corona on PEGylated Liposome and Cellular Uptake","volume":"259","author":"Zheng","year":"2026","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.addr.2020.06.005","article-title":"Exploiting the Dynamics of the EPR Effect and Strategies to Improve the Therapeutic Effects of Nanomedicines by Using EPR Effect Enhancers","volume":"157","author":"Fang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13046-022-02272-x","article-title":"Tumor-Associated Macrophages in Cancer: Recent Advancements in Cancer Nanoimmunotherapies","volume":"41","author":"Kumari","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"11864","DOI":"10.1039\/D4NR04508D","article-title":"More than a Delivery System: The Evolving Role of Lipid-Based Nanoparticles","volume":"17","author":"Karmaker","year":"2025","journal-title":"Nanoscale"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"102757","DOI":"10.1016\/j.cis.2022.102757","article-title":"Liposomes as Biocompatible and Smart Delivery Systems\u2014The Current State","volume":"309","author":"Dymek","year":"2022","journal-title":"Adv. Colloid Interface Sci."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Andrade, S., Loureiro, J.A., Ramirez, S., Catumbela, C.S.G., Soto, C., Morales, R., and Pereira, M.C. (2022). Multi-Dose Intravenous Administration of Neutral and Cationic Liposomes in Mice: An Extensive Toxicity Study. Pharmaceuticals, 15.","DOI":"10.3390\/ph15060761"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1038\/s41467-025-57965-6","article-title":"A Protease-Cleavable Liposome for Co-Delivery of Anti-PD-L1 and Doxorubicin for Colon Cancer Therapy in Mice","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"104014","DOI":"10.1016\/j.drudis.2024.104014","article-title":"Enzyme-Responsive Liposomes for Controlled Drug Release","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov. Today"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Tsirogianni, A.G., Chountoulesi, M., and Pippa, N. (2025). Recent Advances in pH-Responsive Liposomes: Lessons Learnt and New Directions in Nanomedicine Development. Materials, 18.","DOI":"10.3390\/ma18184295"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s12951-024-02859-w","article-title":"Redox-Manipulating Nanocarriers for Anticancer Drug Delivery: A Systematic Review","volume":"22","author":"Meng","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1021\/acs.nanolett.1c01210","article-title":"Detachable Liposomes Combined Immunochemotherapy for Enhanced Triple-Negative Breast Cancer Treatment through Reprogramming of Tumor-Associated Macrophages","volume":"21","author":"Chen","year":"2021","journal-title":"Nano Lett."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1038\/s41467-023-41592-0","article-title":"pH-Gated Nanoparticles Selectively Regulate Lysosomal Function of Tumour-Associated Macrophages for Cancer Immunotherapy","volume":"14","author":"Tang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"103045","DOI":"10.1016\/j.copbio.2023.103045","article-title":"Progress and Challenges in the Translation of Cancer Nanomedicines","volume":"85","author":"Tong","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s43088-024-00566-x","article-title":"Surface-Modified Lipid-Based Nanocarriers as a Pivotal Delivery Approach for Cancer Therapy: Application and Recent Advances in Targeted Cancer Treatment","volume":"13","author":"Anwar","year":"2024","journal-title":"Beni-Suef Univ. J. Basic. Appl. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41565-025-01926-z","article-title":"Balancing Stealth and Targeting to Improve Nanomedicine Efficacy","volume":"20","author":"Ju","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Xin, Y., Ma, Q., Deng, Q., Wang, T., Wang, D., and Wang, G. (2025). Analysis of Single-Cell and Spatial Transcriptomics in TNBC Cell-Cell Interactions. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1521388"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"03946320261438337","DOI":"10.1177\/03946320261438337","article-title":"Liposomal Nanotherapeutics for Cancer Treatment: Targeted Delivery and Immunotherapy","volume":"40","author":"Butt","year":"2026","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Zagana, P., and Paxinou, A. (2026). Advanced Liposomal Systems for Cancer Therapy with Focus on Lipid\u2013Polymer Hybrids and Cell Membrane-Coated Liposomes. Future Pharmacol., 6.","DOI":"10.3390\/futurepharmacol6010006"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40164-025-00602-1","article-title":"Applications of Liposomes and Lipid Nanoparticles in Cancer Therapy: Current Advances and Prospects","volume":"14","author":"Cheng","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_136","first-page":"90","article-title":"Efficacy and Cardiovascular Safety of Liposomal Doxorubicin: A Systematic Review and Meta-Analysis of Randomized Trials","volume":"11","author":"Cavalli","year":"2025","journal-title":"Cardio-Oncol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/annonc\/mdh097","article-title":"Reduced Cardiotoxicity and Comparable Efficacy in a Phase IIItrial of Pegylated Liposomal Doxorubicin HCl(CAELYXTM\/Doxil\u00ae) versus Conventional Doxorubicin Forfirst-Line Treatment of Metastatic Breast Cancer","volume":"15","author":"Wigler","year":"2004","journal-title":"Ann. Oncol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.10201","article-title":"Liposome-encapsulated Doxorubicin Compared with Conventional Doxorubicin in a Randomized Multicenter Trial as First-line Therapy of Metastatic Breast Carcinoma","volume":"94","author":"Harris","year":"2002","journal-title":"Cancer"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1080\/14796694.2025.2574833","article-title":"Nab-Paclitaxel vs Paclitaxel Liposome for Advanced Breast Cancer: Real-World Efficacy and Safety Analysis","volume":"21","author":"Li","year":"2025","journal-title":"Future Oncol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1016\/S2352-3026(21)00134-4","article-title":"CPX-351 versus 7+3 Cytarabine and Daunorubicin Chemotherapy in Older Adults with Newly Diagnosed High-Risk or Secondary Acute Myeloid Leukaemia: 5-Year Results of a Randomised, Open-Label, Multicentre, Phase 3 Trial","volume":"8","author":"Lancet","year":"2021","journal-title":"Lancet Haematol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40265-024-02133-1","article-title":"Liposomal Irinotecan: A Review as First-Line Therapy in Metastatic Pancreatic Adenocarcinoma","volume":"85","author":"Brown","year":"2025","journal-title":"Drugs"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1158\/1078-0432.CCR-18-2990","article-title":"FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia","volume":"25","author":"Krauss","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO-25-00210","article-title":"Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG\/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials","volume":"43","author":"Palmerini","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e001341","DOI":"10.1136\/jitc-2020-001341","article-title":"Tumor-Associated Macrophages: Potential Therapeutic Strategies and Future Prospects in Cancer","volume":"9","author":"Li","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"150908","DOI":"10.1016\/j.bbrc.2024.150908","article-title":"Unraveling the Mechanism of the Anticancer Potential of Emodin Using 2D and Spheroid Models of A549 Cells","volume":"736","author":"Sangseekew","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41420-024-02110-3","article-title":"Endoplasmic Reticulum Stress\u2014A Key Guardian in Cancer","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Matsushima, G., Yanase, Y., Nakagawa, T., Goda, M., Ozawa, K., and Hosoi, T. (2025). Endoplasmic Reticulum Stress and Unfolded Protein Response in Immune Cell Function. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1694102"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41420-025-02862-6","article-title":"Endoplasmic Reticulum Stress-Mediated Programmed Cell Death in the Tumor Microenvironment","volume":"11","author":"Chai","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41587-025-02597-w","article-title":"Turn Cold Tumors Hot by Reprogramming the Tumor Microenvironment","volume":"43","author":"Yuan","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40364-025-00750-w","article-title":"Targeting cGAS-STING Pathway for Reprogramming Tumor-Associated Macrophages to Enhance Anti-Tumor Immunotherapy","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomark. Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41392-023-01462-z","article-title":"Radiation-Induced Tumor Immune Microenvironments and Potential Targets for Combination Therapy","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"e010950","DOI":"10.1136\/jitc-2024-010950","article-title":"Reprogramming Tumor-Associated Macrophages Using STING or TLR Agonists: A Promising Strategy to Enhance Immunotherapy in Hormone-Dependent Cancers","volume":"13","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"122801","DOI":"10.1016\/j.biomaterials.2024.122801","article-title":"Liposomes-Enabled Cancer Chemoimmunotherapy","volume":"313","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"123818","DOI":"10.1016\/j.ijpharm.2024.123818","article-title":"Liposome-Based Nanomedicine for Immune Checkpoint Blocking Therapy and Combinatory Cancer Therapy","volume":"652","author":"Zhou","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"7378","DOI":"10.1039\/D3NR06333J","article-title":"Macrophage-Modulating Nanomedicine for Cancer Immunotherapy","volume":"16","author":"Khan","year":"2024","journal-title":"Nanoscale"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01668-1","article-title":"Multifunctional Nanoparticle-Mediated Combining Therapy for Human Diseases","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ccell.2025.03.006","article-title":"Navigating Established and Emerging Biomarkers for Immune Checkpoint Inhibitor Therapy","volume":"43","author":"Wang","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"e010928","DOI":"10.1136\/jitc-2024-010928","article-title":"Society for Immunotherapy of Cancer (SITC) Consensus Statement on Essential Biomarkers for Immunotherapy Clinical Protocols","volume":"13","author":"Cottrell","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated Liposomes: Immunological Responses","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci. Technol. Adv. Mater."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00403-025-03971-z","article-title":"Unravelling the Complexity of CARPA: A Review of Emerging Advancements in Therapeutic Strategies","volume":"317","author":"Saxena","year":"2025","journal-title":"Arch. Dermatol. Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2023.11.006","article-title":"Activation of the Complement System by Nanoparticles and Strategies for Complement Inhibition","volume":"193","author":"Haroon","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"103044","DOI":"10.1016\/j.copbio.2023.103044","article-title":"Complement-Dependent Uptake of Nanoparticles by Blood Phagocytes: Brief Overview and Perspective","volume":"85","author":"Li","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s44222-025-00281-x","article-title":"Biomaterial Design for Proactive Modulation of the Complement System","volume":"3","author":"Abudousu","year":"2025","journal-title":"Nat. Rev. Bioeng."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Selyutina, O.Y., Ul\u2019yanova, M.A., Chinak, O.A., Timoshnikov, V.A., Fedenok, L.G., Stepanov, A.A., Yanshole, V.V., Kulik, L.V., Vasilevsky, S.F., and Polyakov, N.E. (2024). Novel Anthraquinone Derivatives and Their Complexes with Metal Ions with Anticancer Activity: Structure\/Redox and Chelation Activity Correlations. Pharmaceuticals, 17.","DOI":"10.3390\/ph17121717"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Mantareva, V., Braikova, D., Lazarova, I., and Genova, T. (2024). Plants-Occurring Anthraquinones as Photosensitive Compounds for Photodynamic Method: A Critical Overview. Front. Biosci., 29.","DOI":"10.31083\/j.fbl2905168"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1080\/07391102.2024.2439582","article-title":"Toxicity of Anthraquinone Derivatives in Relation to Non-Linear Optical Properties and Electron Correlation","volume":"44","author":"Gupta","year":"2026","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Yang, X., Jia, Z., Liu, J., Yan, X., Dai, Y., and Xiao, H. (2020). Proteomics Unravels Emodin Causes Liver Oxidative Damage Elicited by Mitochondrial Dysfunction. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00416"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1038\/s41467-025-60167-9","article-title":"Topobexin Targets the Topoisomerase II ATPase Domain for Beta Isoform-Selective Inhibition and Anthracycline Cardioprotection","volume":"16","author":"Karabanovich","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1042\/CS20200301","article-title":"Molecular Mechanisms of Anthracycline Cardiovascular Toxicity","volume":"135","author":"Narezkina","year":"2021","journal-title":"Clin. Sci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41569-025-01126-1","article-title":"Anthracycline-Induced Cardiomyopathy: Risk Prediction, Prevention and Treatment","volume":"22","author":"Fabiani","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"100652","DOI":"10.1016\/j.modpat.2024.100652","article-title":"Spatial Architecture of Single-Cell and Vasculature in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer","volume":"38","author":"Mi","year":"2025","journal-title":"Mod. Pathol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41571-024-00926-7","article-title":"Spatial Landscapes of Cancers: Insights and Opportunities","volume":"21","author":"Chen","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10585-023-10246-2","article-title":"Dissecting the Tumor Microenvironment in Response to Immune Checkpoint Inhibitors via Single-Cell and Spatial Transcriptomics","volume":"41","author":"Liu","year":"2024","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Thamizhchelvan, A.M., Wells, K., Pham, J., Galhena, A., and Kim, W. (2026). Nanomaterial-Enabled Modulation of Tumor-Associated Macrophages and Dendritic Cells to Enhance Cancer Immunotherapy. Nanomaterials, 16.","DOI":"10.3390\/nano16030172"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ccell.2025.02.014","article-title":"Targeting Tumor Monocyte-Intrinsic PD-L1 by Rewiring STING Signaling and Enhancing STING Agonist Therapy","volume":"43","author":"Song","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11051-025-06293-3","article-title":"Scaling Nanopharmaceutical Production for Personalized Medicine: Challenges and Strategies","volume":"27","author":"Costa","year":"2025","journal-title":"J. Nanopart. Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"125202","DOI":"10.1016\/j.ijpharm.2025.125202","article-title":"Navigating Translational Research in Nanomedicine: A Strategic Guide to Formulation and Manufacturing","volume":"671","author":"Zhang","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1039\/D4PM00201F","article-title":"A Brief Overview of Quality by Design Approach for Developing Pharmaceutical Liposomes as Nano-Sized Parenteral Drug Delivery Systems","volume":"1","author":"Atre","year":"2024","journal-title":"RSC Pharm."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/7\/781\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:01:27Z","timestamp":1782464487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/7\/781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":178,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["pharmaceutics18070781"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18070781","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}